International Clinical Trial: Use of artificial intelligence and clinical-lab data in predicting the progression of diabetic kidney disease

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109327) titled 'Use of artificial intelligence and clinical-lab data in predicting the progression of diabetic kidney disease' on April 24.

Study Type: Observational

Study Design: Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable

Primary Sponsor: Dr Cynthia Amrutha

Condition: Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Intervention: Intervention1: Nil: Nil

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 11-05-2026

Target Sample Size: 650

Countries of Re...